EP3962499A4 - Materialien und verfahren zur herstellung von blutprodukten - Google Patents
Materialien und verfahren zur herstellung von blutprodukten Download PDFInfo
- Publication number
- EP3962499A4 EP3962499A4 EP20802506.4A EP20802506A EP3962499A4 EP 3962499 A4 EP3962499 A4 EP 3962499A4 EP 20802506 A EP20802506 A EP 20802506A EP 3962499 A4 EP3962499 A4 EP 3962499A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- materials
- methods
- blood products
- producing blood
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3413—Diafiltration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0281—Apparatus for treatment of blood or blood constituents prior to transfusion, e.g. washing, filtering or thawing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/38—Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
- A61M1/382—Optimisation of blood component yield
- A61M1/385—Optimisation of blood component yield taking into account of the patient characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0644—Platelets; Megakaryocytes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/12—Addition of chemical agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2315/00—Details relating to the membrane module operation
- B01D2315/10—Cross-flow filtration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2315/00—Details relating to the membrane module operation
- B01D2315/16—Diafiltration
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2531/00—Microcarriers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Water Supply & Treatment (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Anesthesiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962843061P | 2019-05-03 | 2019-05-03 | |
US201962936122P | 2019-11-15 | 2019-11-15 | |
PCT/US2020/031172 WO2020227149A1 (en) | 2019-05-03 | 2020-05-01 | Materials and methods for producing blood products |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3962499A1 EP3962499A1 (de) | 2022-03-09 |
EP3962499A4 true EP3962499A4 (de) | 2023-01-25 |
Family
ID=73017071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20802506.4A Pending EP3962499A4 (de) | 2019-05-03 | 2020-05-01 | Materialien und verfahren zur herstellung von blutprodukten |
Country Status (12)
Country | Link |
---|---|
US (4) | US11529587B2 (de) |
EP (1) | EP3962499A4 (de) |
JP (1) | JP2022532262A (de) |
KR (1) | KR20220016092A (de) |
CN (1) | CN114072159A (de) |
AU (2) | AU2020267368B2 (de) |
BR (1) | BR112021021984A2 (de) |
CA (1) | CA3138529A1 (de) |
IL (1) | IL287716A (de) |
NZ (1) | NZ782598A (de) |
SG (1) | SG11202112054WA (de) |
WO (1) | WO2020227149A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3121200A1 (en) | 2018-11-30 | 2020-06-04 | Cellphire, Inc. | Platelets as delivery agents |
US11767511B2 (en) | 2018-11-30 | 2023-09-26 | Cellphire, Inc. | Platelets as delivery agents |
SG11202112054WA (en) | 2019-05-03 | 2021-11-29 | Cellphire Inc | Materials and methods for producing blood products |
CA3147618A1 (en) * | 2019-07-17 | 2021-01-21 | Cellphire, Inc. | Use of platelets in treating infections |
CA3150936A1 (en) | 2019-08-16 | 2021-02-25 | Cellphire, Inc. | Thrombosomes as an antiplatelet agent reversal agent |
CA3170198A1 (en) | 2020-02-04 | 2021-08-12 | Cellphire, Inc | Methods of treating acquired hemophilia with anti-fibrinolytic loaded platelets |
WO2022178191A1 (en) * | 2021-02-17 | 2022-08-25 | Cellphire, Inc. | Freeze-dried platelet derivative compositions for treating anticoagulant-induced coagulopathy |
WO2022178177A1 (en) * | 2021-02-17 | 2022-08-25 | Cellphire, Inc. | Freeze-dried platelet derivative compositions for treating antiplatelet-induced coagulopathy |
CA3212885A1 (en) * | 2021-04-20 | 2022-10-27 | Anand PADMANABHAN | Methods for maintaining long-term platelet viability and activatability |
WO2023081804A1 (en) * | 2021-11-04 | 2023-05-11 | Cellphire, Inc. | Platelet derivative compositions, and methods of making and using such compositions |
WO2023220739A1 (en) | 2022-05-12 | 2023-11-16 | Cellphire, Inc. | Platelet derivative compositions for use in subjects afflicted with hermansky pudlak syndrome or bernard soulier syndrome |
CN115462369B (zh) * | 2022-09-29 | 2023-09-22 | 安徽省立医院(中国科学技术大学附属第一医院) | 一种玻璃化冷冻外泌体保存方法 |
WO2024192173A1 (en) | 2023-03-14 | 2024-09-19 | Cellphire, Inc. | Hla-characterized platelet derivative compositions, and methods of making, selecting and using such compositions |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006020773A2 (en) * | 2004-08-12 | 2006-02-23 | Adlyfe, Inc. | Methods for preparing freeze-dried platelets, compositions comprising freeze-dried platelets, and methods of use |
US8097403B2 (en) * | 2006-12-14 | 2012-01-17 | Cellphire, Inc. | Freeze-dried platelets, method of making and method of use as a diagnostic agent |
Family Cites Families (204)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3928566A (en) | 1970-08-14 | 1975-12-23 | Du Pont | Lyophilized biological products |
US3932943A (en) | 1970-08-14 | 1976-01-20 | E. I. Du Pont De Nemours And Company | Method of preparation of lyophilized biological products |
DE2546166A1 (de) | 1975-10-15 | 1977-04-28 | Behringwerke Ag | Gegerbte thrombozyten |
US4059967A (en) | 1976-02-19 | 1977-11-29 | The Community Blood Council Of Greater New York, Inc. | Process for freezing blood platelets |
US4455299A (en) | 1981-11-20 | 1984-06-19 | Baxter Travenol Laboratories, Inc. | Storage of blood platelets |
US4481189A (en) | 1982-04-14 | 1984-11-06 | New York Blood Center Inc. | Process for preparing sterilized plasma and plasma derivatives |
US4670013A (en) | 1982-12-27 | 1987-06-02 | Miles Laboratories, Inc. | Container for blood and blood components |
US4865871A (en) | 1983-08-23 | 1989-09-12 | Board Of Regents The University Of Texas System | Method for cryopreparing biological tissue |
US5185160A (en) | 1984-06-21 | 1993-02-09 | Prp, Inc. | Platelet membrane microvesicles |
WO1986003122A1 (en) | 1984-11-29 | 1986-06-05 | Curatech, Inc. | Wound healing agents |
US5213814A (en) | 1989-04-10 | 1993-05-25 | Cryopharm Corporation | Lyophilized and reconstituted blood platelet compositions |
US5958670A (en) | 1988-05-18 | 1999-09-28 | Cobe Laboratories, Inc. | Method of freezing cells and cell-like materials |
US4994367A (en) | 1988-10-07 | 1991-02-19 | East Carolina University | Extended shelf life platelet preparations and process for preparing the same |
US5059518A (en) | 1988-10-20 | 1991-10-22 | Coulter Corporation | Stabilized lyophilized mammalian cells and method of making same |
EP0397890B1 (de) | 1988-11-18 | 1994-09-07 | Tosoh Corporation | Verfahren zur reinigung von blutplasma |
US5332578A (en) | 1989-04-14 | 1994-07-26 | Prp, Inc. | Platelet membrane microparticles |
AU650045B2 (en) | 1990-09-12 | 1994-06-09 | Lifecell Corporation | Method and apparatus for cryopreparation dry stabilization and rehydration of biological suspensions |
EP0510185B1 (de) | 1990-11-07 | 1996-12-11 | Baxter International Inc. | Medium zur aufbewahrung von blutplättchen |
DE69132918T2 (de) | 1990-11-27 | 2002-10-31 | American National Red Cross, Washington | Gewebeabdeckung und wachstumsfaktor enthaltende verbindungen zur förderung beschleunigter wundheilung |
GB9114202D0 (en) | 1991-07-01 | 1991-08-21 | Quadrant Holdings Cambridge | Blood products |
CA2128527A1 (en) | 1992-01-21 | 1993-07-22 | Raymond P. Goodrich, Jr. | Method of freezing cells and cell-like materials |
US5423738A (en) | 1992-03-13 | 1995-06-13 | Robinson; Thomas C. | Blood pumping and processing system |
PT642301E (pt) | 1992-05-29 | 2003-06-30 | Univ East Carolina | Plaquetas de sangue humano fixas secas farmaceuticamente aceitaveis |
KR100267604B1 (ko) | 1993-06-04 | 2000-11-01 | 이 세갈 폴 | 혈장 유사 용액 |
US5656498A (en) | 1994-02-22 | 1997-08-12 | Nippon Telegraph And Telephone Corporation | Freeze-dried blood cells, stem cells and platelets, and manufacturing method for the same |
JP3788522B2 (ja) | 1994-02-22 | 2006-06-21 | 日本電信電話株式会社 | 血球、幹細胞、および血小板の凍結乾燥生成物の製造方法 |
US5656598A (en) | 1994-03-08 | 1997-08-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Use of fibroblast growth factors to stimulate bone growth |
US5759542A (en) | 1994-08-05 | 1998-06-02 | New England Deaconess Hospital Corporation | Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases |
US5622867A (en) | 1994-10-19 | 1997-04-22 | Lifecell Corporation | Prolonged preservation of blood platelets |
US5919614A (en) | 1994-10-19 | 1999-07-06 | Lifecell Corporation | Composition comprising three platelet lesion inhibitors for platelet storage |
US20010046487A1 (en) | 1994-12-30 | 2001-11-29 | Roser Bruce J. | Methods for loading platelets, stabilizing platelets for dry storage and compositions obtained thereby |
US5736313A (en) | 1995-10-20 | 1998-04-07 | The United States Of America As Represented By The Secretary Of The Navy | Method of lyophilizing platelets by incubation with high carbohydrate concentrations and supercooling prior to freezing |
AU3214597A (en) | 1996-05-29 | 1998-01-05 | Universal Preservation Technologies, Inc. | Long-term shelf preservation by vitrification |
DE19634313A1 (de) | 1996-08-24 | 1998-02-26 | Behringwerke Ag | Methode zur Stabilisierung von Plättchen |
US5827741A (en) | 1996-11-19 | 1998-10-27 | The Regents Of The University Of California | Cryopreservation of human adult and fetal pancreatic cells and human platelets |
US5817381A (en) | 1996-11-13 | 1998-10-06 | Agricultural Utilization Research Institute | Cellulose fiber based compositions and film and the process for their manufacture |
DK0967862T3 (da) | 1997-02-07 | 2003-05-12 | Elan Drug Delivery Ltd | Fremgangsmåde og præparater til fremstilling af tørrede, lagringsstabile blodplader |
US6139878A (en) | 1998-04-27 | 2000-10-31 | Aventis Behring, Llc | Method for preparing a diafiltered stabilized blood product |
ES2195655T3 (es) | 1998-11-20 | 2003-12-01 | Lilly Co Eli | Procedimiento para tratar fiebre hemorragica virica con proteina c. |
JP2002535373A (ja) | 1999-01-28 | 2002-10-22 | ボード・オヴ・リージェンツ,ザ・ユニヴァーシティ・オヴ・テキサス・システム | トロンボポエチン組成物を使用した収集用および凍結保存のための循環血小板を増加させる方法 |
WO2001007921A2 (en) | 1999-07-23 | 2001-02-01 | Medical Analysis Systems, Inc. | Stabilized coagulation control reagent |
JP4859317B2 (ja) | 1999-08-06 | 2012-01-25 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | 薬剤放出生分解性繊維インプラント |
US7033603B2 (en) | 1999-08-06 | 2006-04-25 | Board Of Regents The University Of Texas | Drug releasing biodegradable fiber for delivery of therapeutics |
US6211575B1 (en) | 1999-08-18 | 2001-04-03 | Sigmatel Inc. | Method and apparatus for identifying customized integrated circuits |
EP1221835B1 (de) | 1999-11-12 | 2003-04-09 | Elan Drug Delivery Limited | Stabilisierung von blutplättchen |
US7208265B1 (en) | 1999-11-24 | 2007-04-24 | Xy, Inc. | Method of cryopreserving selected sperm cells |
ITAL990010U1 (it) | 1999-12-14 | 2001-06-14 | Maria Cristina Sacchi | Nuova metodica di laboratorio per preparare gel e membrane piastriniche ottenute dal concentrato piastrinico. |
US20040152964A1 (en) | 2000-02-10 | 2004-08-05 | Crowe John H. | Method and therapeutic platelets |
US20040147024A1 (en) | 2000-02-10 | 2004-07-29 | Crowe John H. | Therapeutic platelets and methods |
US20040185524A1 (en) | 2000-02-10 | 2004-09-23 | Crowe John H. | Biological samples and method for increasing survival of biological samples |
US20020076445A1 (en) | 2000-02-10 | 2002-06-20 | Crowe John H. | Eukaryotic cells and method for preserving cells |
US6770478B2 (en) | 2000-02-10 | 2004-08-03 | The Regents Of The University Of California | Erythrocytic cells and method for preserving cells |
CA2397362A1 (en) | 2000-02-10 | 2001-08-16 | The Regents Of The University Of California | Therapeutic platelets and methods |
US7696168B2 (en) | 2000-04-21 | 2010-04-13 | Tufts Medical Center, Inc. | G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same |
MXPA02011416A (es) | 2000-05-22 | 2004-08-12 | Arthur C Coffey | Combinacion de submucosa del intestino delgado y vendaje a vacio, y su metodo de utilizacion. |
US6653062B1 (en) | 2000-07-26 | 2003-11-25 | Wisconsin Alumni Research Foundation | Preservation and storage medium for biological materials |
CA2426584C (en) | 2000-10-19 | 2010-08-10 | Bracco Research Usa | Radiopharmaceutical formulations |
US20050222029A1 (en) | 2001-01-04 | 2005-10-06 | Myriad Genetics, Incorporated | Compositions and methods for treating diseases |
US7141425B2 (en) | 2001-08-22 | 2006-11-28 | Maxcyte, Inc. | Apparatus and method for electroporation of biological samples |
EP1446148A1 (de) | 2001-11-09 | 2004-08-18 | Novo Nordisk A/S | Pharmazeutische zusammensetzung mit einem faktor-vii-polypeptid und epsilon-aminocapronsäure |
US20040136974A1 (en) | 2002-01-16 | 2004-07-15 | Crowe John H. | Therapeutic platelets and methods |
JP2003238174A (ja) | 2002-02-15 | 2003-08-27 | Asahi Glass Co Ltd | フロートガラスの製造方法 |
US7806845B2 (en) | 2002-04-24 | 2010-10-05 | Biomet Biologics, Llc | Blood separation and concentration system |
CA2499463A1 (en) | 2002-11-08 | 2004-05-27 | The Brigham And Women's Hospital, Inc. | Compositions and methods for prolonging survival of platelets |
WO2005002499A2 (en) | 2002-11-29 | 2005-01-13 | The Regents Of The University Of California | A method and therapeutic platelets |
WO2004050896A2 (en) | 2002-11-29 | 2004-06-17 | The Regents Of The University Of California | A method and therapeutic platelets |
GB0305133D0 (en) | 2003-03-06 | 2003-04-09 | Sinvent As | Product |
US7294455B2 (en) | 2003-05-16 | 2007-11-13 | The University Of North Carolina At Chapel Hill | Fixed-dried platelets cross-linked to protein |
US20050048460A1 (en) | 2003-05-29 | 2005-03-03 | The Regents Of The University Of California | Preservative and method for preserving cells |
US20060200100A1 (en) | 2003-06-18 | 2006-09-07 | Rosati Coni F | Method and apparatus for supplying gas to an area |
JP2005053841A (ja) | 2003-08-05 | 2005-03-03 | Kyouto Biomedical Science:Kk | 皮膚外用剤 |
DE10335833A1 (de) | 2003-08-05 | 2005-03-03 | Curevac Gmbh | Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie |
US20060223050A1 (en) | 2003-08-06 | 2006-10-05 | The Regents Of The University Of California Office Of Technology Transfer | Therapeutic platelets and methods |
GB0323378D0 (en) | 2003-10-07 | 2003-11-05 | Univ Leicester | Therapeutic agent |
US20050181978A1 (en) | 2003-11-20 | 2005-08-18 | Rasmus Rojkjaer | Therapeutic use of factor XI |
US7678780B2 (en) | 2003-12-29 | 2010-03-16 | Allan Mishra | Method of treating cancer using platelet releasate |
US20050191286A1 (en) | 2004-02-09 | 2005-09-01 | Gandy James B. | Lyophilized platelet rich plasma for the use in wound healing (chronic or acute) and bone or tissue grafts or repair |
US7794720B2 (en) | 2004-02-18 | 2010-09-14 | Plasma Ventures Pty Ltd | Isolated plasma and method for hyperimmunisation and plasma collection |
US20060051731A1 (en) | 2004-08-12 | 2006-03-09 | David Ho | Processes for preparing lyophilized platelets |
US7811558B2 (en) | 2004-08-12 | 2010-10-12 | Cellphire, Inc. | Use of stabilized platelets as hemostatic agent |
US20060035383A1 (en) | 2004-08-12 | 2006-02-16 | David Ho | Dry platelet preparations for use in diagnostics |
US20060095121A1 (en) | 2004-10-28 | 2006-05-04 | Medtronic Vascular, Inc. | Autologous platelet gel on a stent graft |
WO2006059329A1 (en) | 2004-12-01 | 2006-06-08 | Hadasit Medical Research Services & Development Limited | Platelet-derived microparticles for therapy |
US20080299212A1 (en) | 2005-02-25 | 2008-12-04 | Medigenes Co., Ltd | Pharmaceutical Composition for Treating Avellino Cornea Dystrophy Comprising Blood Plasma or Serum |
WO2008048228A2 (en) | 2005-08-12 | 2008-04-24 | Department Of The Army | Glycine stabilized lyophilized plasma |
WO2008048229A2 (en) | 2005-08-12 | 2008-04-24 | Department Of The Army | Stabilized lyophilized blood platelets |
WO2007038629A2 (en) | 2005-09-26 | 2007-04-05 | Lifecell Corporation | Dry platelet composition |
US20070087061A1 (en) | 2005-10-14 | 2007-04-19 | Medafor, Incorporated | Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components |
US20070178104A1 (en) | 2006-01-31 | 2007-08-02 | Awdalla Essam T | Methods and means for treating solid tumors |
EP2019858B1 (de) | 2006-04-17 | 2012-06-13 | BioE LLC | Differenzierung von vorläuferzellen mit mehreren abstammungslinien in respiratorischen epithelzellen |
US20070243137A1 (en) | 2006-04-18 | 2007-10-18 | Nanoprobes, Inc. | Cell and sub-cell methods for imaging and therapy |
US8529959B2 (en) | 2006-10-17 | 2013-09-10 | Carmell Therapeutics Corporation | Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
US8790924B2 (en) | 2006-10-19 | 2014-07-29 | Duke University | Reversible platelet inhibition |
WO2008073491A1 (en) | 2006-12-11 | 2008-06-19 | University Of Florida Research Foundation, Inc. | System and method for analyzing progress of labor and preterm labor |
EP1958618A1 (de) | 2007-02-15 | 2008-08-20 | Octapharma AG | Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren |
US20110020107A1 (en) | 2007-03-23 | 2011-01-27 | Flodesign Wind Turbine Corporation | Molded wind turbine shroud segments and constructions for shrouds |
US8512697B2 (en) | 2007-05-16 | 2013-08-20 | The University Of North Carolina At Chapel Hill | Delivery of micro- and nanoparticles with blood platelets |
DE102007028090A1 (de) | 2007-06-12 | 2008-12-18 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Aktivierbare diagnostische und therapeutische Verbindung |
EP2190450A2 (de) | 2007-09-11 | 2010-06-02 | Mondobiotech Laboratories AG | Verwendung von melaninkonzentrierendem hormon und met-enkephalin als therapeutika |
US8349367B2 (en) | 2007-10-12 | 2013-01-08 | Bakaltcheva Irina B | Freeze-dried plasma formats for the trauma care field |
WO2009058876A1 (en) | 2007-10-29 | 2009-05-07 | Beckman Coulter, Inc. | Method for a rapid antibody-based analysis of platelet populations |
US20110008804A1 (en) | 2007-11-05 | 2011-01-13 | Kain Kevin C | Angiopoietin-1 and -2 biomarkers for infectious diseases that compromise endothelial integrity |
US8906855B2 (en) | 2007-12-22 | 2014-12-09 | Vivacelle Bio, Inc. | Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
TW200930811A (en) | 2008-01-04 | 2009-07-16 | Univ Nat Taiwan Science Tech | Transfection reagent and method for enhancing transfection efficiency |
EP2077118A1 (de) | 2008-01-07 | 2009-07-08 | Gwo Rei Biomedical Technology Corp. | Gerinnungsfähiges Konzentrat von Plättchenwachstumsfaktoren und Herstellungsverfahren dafür |
EP2259774B1 (de) | 2008-02-27 | 2012-12-12 | Biomet Biologics, LLC | Verfahren und zusammensetzungen zur abgabe eines interleukin-1-rezeptor-antagonisten |
EP2286223B1 (de) | 2008-05-02 | 2016-07-06 | University Of Rochester | Detektorsystem in arrayform zur messung einer influenza-immunantwort |
US20100055067A1 (en) | 2008-08-26 | 2010-03-04 | Snu R&Db Foundation | Perfluorocarbon conjugate as a blood substitute |
WO2010046949A1 (ja) | 2008-10-22 | 2010-04-29 | Inui Hiroaki | 細胞をガラス化保存する方法および細胞のガラス化保存用容器 |
CN102300555B (zh) | 2009-01-30 | 2015-06-17 | 卡斯伯特·O·辛普金斯 | 复苏液 |
CN102317447B (zh) | 2009-05-07 | 2015-06-10 | 加米达细胞有限公司 | 用于筛选扩增的干细胞群的方法 |
US8715920B2 (en) | 2010-07-27 | 2014-05-06 | Biovec Transfusion, Llc | Composition for preserving platelets during photosensitization |
EP2266635A1 (de) | 2009-06-26 | 2010-12-29 | Aarhus Universitet | Hybridgerüst mit dreidimensionaler Nanostruktur und Herstellung davon |
WO2011020107A2 (en) | 2009-08-14 | 2011-02-17 | Georgetown University | Compositions and methods for detection and treatment of breast cancer |
WO2011083472A2 (en) | 2010-01-07 | 2011-07-14 | Core Dynamics Ltd. | Method for preserving cancellous bone samples and preserved cancellous bone tissue |
US20110183311A1 (en) | 2010-01-27 | 2011-07-28 | David Ho | Dry platelet preparations for use in diagnostics |
WO2011103114A1 (en) | 2010-02-17 | 2011-08-25 | Hememics Biotechnologies, Inc. | Preservation solutions for biologics and methods related thereto |
EP2555918A1 (de) | 2010-04-06 | 2013-02-13 | Genvault Corporation | Stabilisierte chemische dehydrierung biologischer materialien |
US9061043B2 (en) | 2010-10-13 | 2015-06-23 | Duke University | Aptamers to glycoprotein VI |
CN103476932A (zh) | 2010-10-14 | 2013-12-25 | 雷加多生物科学公司 | Clec-2的核酸调节剂 |
US20140083628A1 (en) | 2012-09-27 | 2014-03-27 | Velico Medical, Inc. | Spray drier assembly for automated spray drying |
WO2012071135A2 (en) * | 2010-11-23 | 2012-05-31 | Biovec Transfusion, Llc | Methods for removing pathogens from a platelet preparation |
US20120134974A1 (en) | 2010-11-30 | 2012-05-31 | Biovec Transfusion, Llc | Methods for removing plasma |
IL210162A0 (en) * | 2010-12-21 | 2011-03-31 | Omrix Biopharmaceuticals | Viral inactivated platelet extract, use and preparation thereof |
JP2012143554A (ja) | 2010-12-24 | 2012-08-02 | Toray Ind Inc | ポリスルホン系中空糸膜及び血小板浮遊液浄化用中空糸膜モジュール並びに血小板浮遊液の浄化方法 |
EP3662750A1 (de) | 2011-04-07 | 2020-06-10 | Fenwal, Inc. | Automatisierte verfahren und systeme zur bereitstellung von thrombozytenkonzentraten mit reduziertem restplasmavolumen und medien zur lagerung solcher thrombozytenkonzentrate |
US20120321722A1 (en) | 2011-05-17 | 2012-12-20 | Qiyong Peter Liu | Platelet Storage and Reduced Bacterial Proliferation In Platelet Products Using A Sialidase Inhibitor |
AU2012275562B2 (en) | 2011-06-27 | 2016-10-20 | Children's Healthcare Of Atlanta, Inc. | Compositions, uses, and preparation of platelet lysates |
SG10201601960SA (en) | 2011-09-14 | 2016-04-28 | American Regenerative Technologies Llc | Inhalation systems, breathing apparatuses, and methods |
KR101410065B1 (ko) | 2011-12-09 | 2014-06-27 | 테고사이언스 (주) | 세포의 유용물질을 상온에서 안정하게 보존하는 방법 |
US9682104B2 (en) | 2012-01-26 | 2017-06-20 | Jadi Cell Llc | Lyophilized platelet lysates |
CN103524613A (zh) | 2012-07-04 | 2014-01-22 | 晶光源生技股份有限公司 | 皮肤更新生长因子及其于皮肤保养的用途及含其的保养品 |
WO2014051537A1 (en) | 2012-09-25 | 2014-04-03 | Biovec Transfusion, Llc | Device and method for removing additives in the blood products |
EP2903646A1 (de) | 2012-10-04 | 2015-08-12 | Genesys Research Institute | Kaffeezusammensetzungen und verwendungen davon |
WO2014066142A1 (en) | 2012-10-24 | 2014-05-01 | Novamedica Limited Liability Company | Nucleic acid regulation of growth arrest-specific protein 6 (gas6) |
BR112015009229B1 (pt) | 2012-10-24 | 2021-07-20 | Platelet Targeted Therapeutics, Llc | Composição tendo como alvo a expressão de genes para plaquetas, uso de uma célula tronco compreendendo a referida composição para tratar hemofilia e método in vitro ou ex vivo para gerar uma célula tronco modificada |
CA2893039C (en) | 2012-11-30 | 2021-09-28 | Toray Industries, Inc. | Method for preparing platelet solution replaced with artificial preservation solution |
CA2896053A1 (en) | 2012-12-21 | 2014-06-26 | Ocata Therapeutics, Inc. | Methods for production of platelets from pluripotent stem cells and compositions thereof |
ITRM20130054A1 (it) | 2013-01-30 | 2014-07-31 | Paolo Gresele | Piastrine trasfettate con materiale genetico esogeno e microparticelle derivate da dette piastrine trasfettate, metodo per la loro preparazione e loro usi. |
US9895418B2 (en) | 2013-03-15 | 2018-02-20 | Biomet Biologics, Llc | Treatment of peripheral vascular disease using protein solutions |
US9878011B2 (en) | 2013-03-15 | 2018-01-30 | Biomet Biologics, Llc | Treatment of inflammatory respiratory disease using biological solutions |
US9950035B2 (en) | 2013-03-15 | 2018-04-24 | Biomet Biologics, Llc | Methods and non-immunogenic compositions for treating inflammatory disorders |
CA2922634A1 (en) | 2013-08-27 | 2015-03-05 | Mayo Foundation For Medical Education And Research | Cross-linked platelet material |
WO2015041628A1 (en) | 2013-09-17 | 2015-03-26 | Becton, Dickinson And Company | Stabilization of blood ph during sample storage |
AU2014337190A1 (en) | 2013-10-16 | 2016-06-02 | Liferaft Biosciences, Inc. | Diuretic induced alterations of plasma volume |
CA2928822C (en) | 2013-10-29 | 2022-03-29 | Bloodcenter Research Foundation | Method of detecting platelet activating antibodies that cause heparin-induced thrombocytopenia/thrombosis |
WO2015073587A2 (en) | 2013-11-18 | 2015-05-21 | Rubius Therapeutics, Inc. | Synthetic membrane-receiver complexes |
WO2015109220A1 (en) | 2014-01-17 | 2015-07-23 | President And Fellows Of Harvard College | Platelet decoy and use thereof |
CN103907595A (zh) | 2014-04-18 | 2014-07-09 | 赵树铭 | 含海藻糖的血小板低温保存液及其应用 |
CN106461327B (zh) | 2014-06-09 | 2019-12-13 | 泰尔茂比司特公司 | 冻干法 |
EP3154338B1 (de) | 2014-06-10 | 2020-01-29 | Biomatrica, INC. | Stabilisierung von thrombozyten bei umgebungstemperatur |
ES2884256T3 (es) | 2014-06-10 | 2021-12-10 | Biomatrica Inc | Métodos y composiciones para la estabilización de ácidos nucleicos en una muestra de sangre a temperaturas ambientales |
EP3194576B1 (de) | 2014-07-23 | 2020-11-18 | Cerus Corporation | Verfahren zur herstellung von thrombozyten-produkten |
WO2016036807A1 (en) | 2014-09-03 | 2016-03-10 | Entegrion, Inc. | Acceleration of reconstitution of plasma powder by mixing with small beads |
US9561184B2 (en) | 2014-09-19 | 2017-02-07 | Velico Medical, Inc. | Methods and systems for multi-stage drying of plasma |
WO2016057041A1 (en) | 2014-10-09 | 2016-04-14 | Biovec Transfusion, Llc | Compositions and methods for preserving platelet function |
CA3005311A1 (en) | 2014-11-14 | 2016-05-19 | Cellphire, Inc. | Products and devices for controlling and stopping bleeding and methods of using |
EP3265116B1 (de) | 2015-03-04 | 2021-06-02 | University of Rochester | Systemische und topische anwendung von thrombozytenmikropartikel zur behandlung von blutungen bei traumapatienten |
WO2016164693A1 (en) | 2015-04-10 | 2016-10-13 | Board Of Regents, The University Of Texas System | Compositions and methods for prolonged cell storage |
EP3307283B1 (de) | 2015-06-10 | 2020-09-02 | Cellphire Inc. | Zusammensetzung und verfahren zur behandlung des verlustes von flüssigkeiten mit folgender hypotonie und/oder hypovolämie |
WO2016205009A1 (en) | 2015-06-19 | 2016-12-22 | The Regents Of The University Of California | Treating infection by a platelet-targeting microbe using nanoparticles |
WO2017027760A1 (en) | 2015-08-12 | 2017-02-16 | North Carolina State University | Platelet membrane-coated drug delivery system |
WO2017040238A1 (en) | 2015-08-28 | 2017-03-09 | Cellphire, Inc. | Products and methods using a platelet-derived hemostatic agent for controlling bleeding and improving healing |
US20230248772A1 (en) | 2015-08-28 | 2023-08-10 | Cellphire, Inc. | Products and methods using a platelet-derived hemostatic agent for controlling bleeding and improving healing |
WO2017075038A1 (en) | 2015-10-26 | 2017-05-04 | Rana Therapeutics, Inc. | Nanoparticle formulations for delivery of nucleic acid complexes |
EP3377645B1 (de) | 2015-11-20 | 2023-10-04 | Qiagen GmbH | Verfahren zur herstellung sterilisierter zusammensetzungen zur stabilisierung von extrazellulären nukleinsäuren |
EP3402873A4 (de) | 2016-01-14 | 2019-08-21 | Cellphire Inc. | Konservierung nukleierter zellen durch lyophilisierung |
CA3035650A1 (en) | 2016-09-01 | 2018-03-08 | Plas-Free Ltd | Human blood-derived products having decreased fibrinolytic activity and uses thereof in hemostatic disorders |
TWI670371B (zh) | 2016-10-04 | 2019-09-01 | 全崴生技股份有限公司 | 用於細胞冷凍保存的組成物和方法 |
AU2016431615A1 (en) | 2016-12-08 | 2019-06-20 | Cellphire, Inc. | Compositions and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia |
US20230112136A1 (en) | 2017-09-13 | 2023-04-13 | Cellphire, Inc. | Canine blood platelet preparations |
EP3681518A4 (de) | 2017-09-13 | 2021-06-23 | Cellphire Inc. | Blutplättchenpräparate aus hunden |
JP7110360B2 (ja) | 2017-10-09 | 2022-08-01 | テルモ ビーシーティー バイオテクノロジーズ,エルエルシー | 凍結乾燥方法 |
CN108715834B (zh) | 2018-06-01 | 2021-09-14 | 天晴干细胞股份有限公司 | 一种富含cd41+、cd81+微囊的血小板裂解液制备方法 |
SG11202100759WA (en) | 2018-07-27 | 2021-02-25 | Cellphire Inc | Cryopreserved platelet compositions and methods for making |
CA3015457A1 (en) | 2018-08-24 | 2020-02-24 | Bloodworks | Methods to reduce clot formation in cold-stored platelet products |
US20200060262A1 (en) | 2018-08-24 | 2020-02-27 | Bloodworks | Methods to reduce clot formation in cold-stored platelet products |
US11088715B2 (en) | 2018-08-31 | 2021-08-10 | TE Connectivity Services Gmbh | Communication system having a receptacle cage with an airflow channel |
CA3112455A1 (en) | 2018-09-11 | 2020-03-19 | Cellphire, Inc. | Blood plasma-containing compositions |
CN109942687B (zh) | 2018-10-16 | 2020-07-03 | 哈尔滨医科大学 | 68Ga标记EACA修饰c-Met分子成像探针及制备与应用 |
CA3121200A1 (en) | 2018-11-30 | 2020-06-04 | Cellphire, Inc. | Platelets as delivery agents |
US20230248771A1 (en) | 2018-11-30 | 2023-08-10 | Cellphire, Inc. | Platelets loaded with anti-cancer agents |
US11767511B2 (en) | 2018-11-30 | 2023-09-26 | Cellphire, Inc. | Platelets as delivery agents |
US20210180016A1 (en) | 2019-11-27 | 2021-06-17 | Cellphire, Inc. | PLATELETS LOADED WITH mRNA |
AU2020221966A1 (en) | 2019-02-13 | 2021-09-30 | Takeda Pharmaceutical Company Limited | Cryopreservation of stem cells |
WO2020186193A1 (en) | 2019-03-13 | 2020-09-17 | Cellphire, Inc. | Canine blood platelet preparations |
SG11202112054WA (en) | 2019-05-03 | 2021-11-29 | Cellphire Inc | Materials and methods for producing blood products |
CA3147618A1 (en) | 2019-07-17 | 2021-01-21 | Cellphire, Inc. | Use of platelets in treating infections |
CA3150936A1 (en) | 2019-08-16 | 2021-02-25 | Cellphire, Inc. | Thrombosomes as an antiplatelet agent reversal agent |
US20220168353A1 (en) | 2019-08-16 | 2022-06-02 | Cellphire Inc. | Freeze-dried platelet derivative compositions for treating antiplatelet induced coagulopathy |
WO2021034716A1 (en) | 2019-08-16 | 2021-02-25 | Cellphire, Inc. | Thrombosomes as an anticoagulant reversal agent |
WO2021046409A1 (en) | 2019-09-05 | 2021-03-11 | Cellphire, Inc. | Materials and methods for blood plasma preparations |
US20210189341A1 (en) | 2019-11-27 | 2021-06-24 | Cellphire, Inc. | Platelet diagnostic imaging agents |
US20230073676A1 (en) | 2020-02-03 | 2023-03-09 | Malta Inc. | Pumped heat electric storage system with dual-clutch powertrain system |
CA3170198A1 (en) | 2020-02-04 | 2021-08-12 | Cellphire, Inc | Methods of treating acquired hemophilia with anti-fibrinolytic loaded platelets |
WO2021232015A1 (en) | 2020-05-15 | 2021-11-18 | Cellphire, Inc. | Platelet derived extracellular vesicles |
WO2022103861A1 (en) | 2020-11-10 | 2022-05-19 | Cellphire, Inc. | Freeze-dried peripheral blood mononuclear cell compositions and methods |
WO2022178177A1 (en) | 2021-02-17 | 2022-08-25 | Cellphire, Inc. | Freeze-dried platelet derivative compositions for treating antiplatelet-induced coagulopathy |
WO2022178191A1 (en) | 2021-02-17 | 2022-08-25 | Cellphire, Inc. | Freeze-dried platelet derivative compositions for treating anticoagulant-induced coagulopathy |
US20220279777A1 (en) | 2021-02-17 | 2022-09-08 | Cellphire Inc. | Freeze-dried platelet derivative compositions for treating anticoagulant-induced coagulopathy |
US20220273724A1 (en) | 2021-02-17 | 2022-09-01 | Cellphire Inc. | Freeze-dried platelet derivative compositions for treating antiplatelet induced coagulopathy |
CN113101737B (zh) * | 2021-03-04 | 2023-09-15 | 京美生命科技(杭州)有限公司 | 一种亲和切向流过滤系统及其构建方法和外泌体提取方法及应用 |
WO2023081804A1 (en) | 2021-11-04 | 2023-05-11 | Cellphire, Inc. | Platelet derivative compositions, and methods of making and using such compositions |
US20230149467A1 (en) | 2021-11-04 | 2023-05-18 | Cellphire, Inc. | Platelet derivative compositions, and methods of making and using such compositions |
-
2020
- 2020-05-01 SG SG11202112054WA patent/SG11202112054WA/en unknown
- 2020-05-01 JP JP2022512705A patent/JP2022532262A/ja active Pending
- 2020-05-01 BR BR112021021984A patent/BR112021021984A2/pt unknown
- 2020-05-01 KR KR1020217039669A patent/KR20220016092A/ko unknown
- 2020-05-01 US US16/865,215 patent/US11529587B2/en active Active
- 2020-05-01 WO PCT/US2020/031172 patent/WO2020227149A1/en unknown
- 2020-05-01 AU AU2020267368A patent/AU2020267368B2/en active Active
- 2020-05-01 NZ NZ782598A patent/NZ782598A/en unknown
- 2020-05-01 EP EP20802506.4A patent/EP3962499A4/de active Pending
- 2020-05-01 CA CA3138529A patent/CA3138529A1/en active Pending
- 2020-05-01 CN CN202080048816.5A patent/CN114072159A/zh active Pending
-
2021
- 2021-10-31 IL IL287716A patent/IL287716A/en unknown
-
2022
- 2022-11-16 US US18/056,220 patent/US11752468B2/en active Active
-
2023
- 2023-01-20 US US18/099,796 patent/US11813572B2/en active Active
- 2023-06-26 US US18/341,700 patent/US20230356150A1/en active Pending
- 2023-07-31 AU AU2023210528A patent/AU2023210528A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006020773A2 (en) * | 2004-08-12 | 2006-02-23 | Adlyfe, Inc. | Methods for preparing freeze-dried platelets, compositions comprising freeze-dried platelets, and methods of use |
US8097403B2 (en) * | 2006-12-14 | 2012-01-17 | Cellphire, Inc. | Freeze-dried platelets, method of making and method of use as a diagnostic agent |
Non-Patent Citations (2)
Title |
---|
BYNUM JAMES A. ET AL: "Evaluation of a lyophilized platelet-derived hemostatic product", TRANSFUSION, vol. 59, no. S2, 1 April 2019 (2019-04-01), US, pages 1490 - 1498, XP055963392, ISSN: 0041-1132, Retrieved from the Internet <URL:https://onlinelibrary.wiley.com/doi/full-xml/10.1111/trf.15167> DOI: 10.1111/trf.15167 * |
G. MICHAEL FITZPATRICK ET AL: "Thrombosomes: a platelet-derived hemostatic agent for control of noncompressible hemorrhage", TRANSFUSION, vol. 53, no. S1, 1 January 2013 (2013-01-01), US, pages 100S - 106S, XP055517518, ISSN: 0041-1132, DOI: 10.1111/trf.12043 * |
Also Published As
Publication number | Publication date |
---|---|
WO2020227149A1 (en) | 2020-11-12 |
US20230356150A1 (en) | 2023-11-09 |
US11813572B2 (en) | 2023-11-14 |
KR20220016092A (ko) | 2022-02-08 |
JP2022532262A (ja) | 2022-07-13 |
NZ782598A (en) | 2024-05-31 |
BR112021021984A2 (pt) | 2022-03-03 |
SG11202112054WA (en) | 2021-11-29 |
AU2020267368A1 (en) | 2021-12-23 |
CA3138529A1 (en) | 2020-11-12 |
AU2023210528A1 (en) | 2023-08-17 |
IL287716A (en) | 2021-12-01 |
US20230226493A1 (en) | 2023-07-20 |
US11529587B2 (en) | 2022-12-20 |
US20200346167A1 (en) | 2020-11-05 |
US11752468B2 (en) | 2023-09-12 |
AU2020267368B2 (en) | 2023-05-04 |
CN114072159A (zh) | 2022-02-18 |
EP3962499A1 (de) | 2022-03-09 |
US20230158455A1 (en) | 2023-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3962499A4 (de) | Materialien und verfahren zur herstellung von blutprodukten | |
EP3998311A4 (de) | Biologisch abbaubares produkt und verfahren zu seiner herstellung | |
EP3894068A4 (de) | Verfahren und reaktor zur herstellung von einem oder mehreren produkten | |
EP3700361A4 (de) | Tabakprodukt und verfahren zur herstellung davon | |
EP3853390A4 (de) | Legierungen auf der basis von platin-nickel, produkte und verfahren zu ihrer herstellung und verwendung | |
EP3833773A4 (de) | Screening-verfahren für hautprodukte | |
EP3854819A4 (de) | Nanocellulose und verfahren zur herstellung davon | |
EP3919188A4 (de) | Holzprodukt und herstellungsverfahren dafür | |
EP3705140A4 (de) | Unter verwendung von kollagen hergestelltes medizinisches material und verfahren zur herstellung davon | |
EP3925954A4 (de) | Fluorlacton und verfahren zur herstellung davon | |
EP3857502A4 (de) | Computerimplementiertes verfahren, vorrichtung und computerprogrammprodukt | |
EP3640258A4 (de) | Neues polypeptid und verfahren zur herstellung eines produkts auf ornithinbasis damit | |
EP3929191A4 (de) | Verfahren zur herstellung von voriconazol und zwischenprodukt davon | |
EP4005640A4 (de) | Kosmetikum und verfahren zur herstellung des kosmetikums | |
EP3782963A4 (de) | Glasmaterial für emaille, emailleprodukt und verfahren zur herstellung eines emailprodukts | |
EP3708175A4 (de) | Medizinisches produkt zur geweberegeneration und herstellungsverfahren dafür | |
EP3919189A4 (de) | Holzprodukt und herstellungsverfahren dafür | |
EP3833691A4 (de) | Humane pd-l1-antikörper | |
EP3566588A4 (de) | Verfahren zur herstellung von lebensmittelmaterial sowie lebensmittelmaterial | |
EP3865423A4 (de) | Einzeldosierte filterkaffeeeinheit und verfahren zur herstellung und zum aufgiessen der einheit | |
EP3747418A4 (de) | Funktionales lebensmittel und verfahren zur herstellung davon | |
EP3766619A4 (de) | Verfahren zur herstellung von formteilen und formteil | |
EP4073258A4 (de) | Verfahren und materialien zur herstellung identifizierbarer methanogener produkte | |
EP3640257A4 (de) | Neues polypeptid und verfahren zur herstellung eines ornithinbasierten produkts damit | |
EP3960240A4 (de) | Pharmazeutisches präparat und verfahren zur herstellung davon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20211122 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40071151 Country of ref document: HK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20230104 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 7/02 20060101ALI20221222BHEP Ipc: A61M 1/34 20060101ALI20221222BHEP Ipc: A61K 35/14 20150101ALI20221222BHEP Ipc: A61K 35/19 20150101AFI20221222BHEP |